CHAPEL HILL, N.C., Oct. 23, 2015 /PRNewswire/ -- Recent regulatory reforms and changes in market dynamics have spurred a shift away from independent clinics to highly influential healthcare providers like Accountable Care Organizations (ACOs) and Integrated Delivery Networks (IDNs). The rapid evolution of these networks has challenged biopharma and medical device companies to adapt their access, pricing and service delivery systems to reflect the rising influence of these networks.
According to recent research from benchmarking firm, Best Practices, LLC, companies are investing in more ACO/IDN facing full-time employees (FTEs) to meet the increasing demands of these networks. In the past 24 months, 59% of organizations added FTEs to support ACO/IDN customers. Going forward, 71% of organizations anticipate adding more FTEs in these roles.
The related report, "Reshaping Commercial Models to Serve ACOs, IDNs, and Emerging Provider Networks," assesses relative impact and priority of key practices and failure points that influence overall ACO/IDN/Large Hospital Network service performance.
Key study topics include:
- Resource Deployment
- Change Management Activities
- Sales Force Structure
- Coordination And Knowledge Sharing
- Customer Targeting and Segmentation
- Understanding Care Delivery Models
- Identifying Decision Makers
- Strategies To Improve Performance
- Employing Health Outcomes
- Lessons Learned And Trends
Best Practices engaged 36 leaders at 31 pharmaceutical and medical device companies through a benchmarking survey. In addition, analysts conducted in-depth executive interviews to develop qualitative findings and insights.
To access the full report, or to download a complimentary summary containing insights found in this report, click on the following link: http://www.best-in-class.com/rr1389.htm
For more information on other recent primary research studies, contact us at 919.403.0251. For related research, visit our Best Practices, LLC website at http://www.best-in-class.com/.
ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.
SOURCE Best Practices, LLC